| Gene symbol | TM4SF1 | Synonyms | H-L6, L6, M3S1, TAAL6 | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q25.1 | dbXrefs | |
| Description | transmembrane 4 L six family member 1 | ||||
| GTO ID | GTC0863 |
| Trial ID | ChiCTR2000033564 |
| Disease | Solid Tumor |
| Altered gene | TM4SF1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TM4SF1 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Clinical trial of the safety and efficacy of chimeric antigen receptor T cells in the treatment of tm4sf1-positive recurrent/refractory solid tumors |
| Year | 2020 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Zhengzhou University |
| Cohort 1 | |||||||||
|
|||||||||